Eloxx Pharmaceuticals Inc
F:3970
Eloxx Pharmaceuticals Inc
F:3970
Price:
3.195
EUR
Market Closed
Market Cap:
€8.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Eloxx Pharmaceuticals Inc
F:3970
|
US |
|
T
|
Top Gum Industries Ltd
TASE:TPGM
|
IL |
|
B
|
Bursa Cimento Fabrikasi AS
IST:BUCIM.E
|
TR |
|
Matinas BioPharma Holdings Inc
F:6LJ
|
US |
|
H
|
Hansol Inticube Co Ltd
KOSDAQ:070590
|
KR |
|
LG Electronics Inc
KRX:066570
|
KR |
|
C
|
Cambium Global Timberland Ltd
XBER:TM1
|
JE |
|
P
|
PCF Group SA
WSE:PCF
|
PL |
|
Fiera Capital Corp
TSX:FSZ
|
CA |
|
A
|
Australian Vanadium Ltd
OTC:ATVVF
|
AU |
|
W
|
Worthington Steel Inc
NYSE:WS
|
US |
|
Guangdong Tengen Industrial Group Co Ltd
SZSE:003003
|
CN |
|
G
|
Gaming Factory SA
WSE:GIF
|
PL |
|
Soluciones Cuatroochenta SA
F:5XW
|
ES |
|
F
|
Froy ASA
OSE:FROY
|
NO |
|
E
|
Equites Property Fund Ltd
JSE:EQU
|
ZA |
|
B
|
Ball Corp
NYSE:BALL
|
US |
|
K
|
Klil Industries Ltd
TASE:KLIL
|
IL |
|
Quickstep Holdings Ltd
OTC:QCKSF
|
AU |
|
C
|
Choong Ang Vaccine Laboratory
KOSDAQ:072020
|
KR |
|
NPO Nauka PAO
MOEX:NAUK
|
RU |
|
Kalray SA
PAR:ALKAL
|
FR |
|
Doganlar Mobilya Grubu Imalat Sanayi ve Ticaret AS
IST:DGNMO.E
|
TR |
|
P
|
Pera Yatirim Holding AS
IST:PEHOL.E
|
TR |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of Eloxx Pharmaceuticals Inc.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Not Available
Multiples Across Competitors
Competitors Multiples
Eloxx Pharmaceuticals Inc Competitors
Eloxx Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Eloxx Pharmaceuticals Inc
F:3970
|
8.8m EUR | 0 | -0.5 | -0.4 | -0.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.3 | 28 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 5.8 | 26.7 | 17.1 | 21.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.5B GBP | 5.2 | 29.8 | 16.5 | 23.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5 | 20.2 | 12.5 | 16.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.7 | 11.1 | 8.2 | 9.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.5B GBP | 2.6 | 15.1 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
